DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

PTC Therapeutics, Inc. (NASDAQ: PTCT)

28.35 1.43 (5.31%)

Quote as of


company name or ticker

Recent Quotes

PTCT $28.35 5.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.22
Previous Close $26.92
Daily Range $27.21 - $28.45
52-Week Range $13.15 - $34.65
Market Cap $852.6M
P/E Ratio -5.20
Dividend (Yield) $0.00 (0.0%)
Volume 316,992
Average Daily Volume 289,857
Current FY EPS -$2.96

Sector

Industry

PTC Therapeutics, Inc. (PTCT) Description

PTC Therapeutics, Inc. Website: http://www.ptcbio.com/

News & Commentary

Companies Limp Towards a Duchenne Treatment – Is There Hope of a Finish Line?

2014 starts a dismal year for Duchenne prospects by Sarepta, Prosensa, PTC and Retrophin

Sector Update: Healthcare Shares Flat Pre-Market

Sector Update: Healthcare

PTC Therapeutics Initiates Confirmatory Phase 3 Clinical Trial of Translarna™ (ataluren) in Patients

PTC Therapeutics Initiates Confirmatory Phase 3 Clinical Trial of Translarna™ (ataluren) in Patients With Nonsense Mutation Cystic Fibrosis (nmCF)

Cramer's Lightning Round - The Street Is Addicted To Qualcomm (6/9/14)

Prosensa to Seek U.S. Approval for DMD Drug

PTC Therapeutics Up on Positive CHMP Opinion - Analyst Blog

Strength Seen in PTC Therapeutics, Inc. (PTCT) as Stock Shoots up 30.74% - Tale of the Tape

Small Advances for Healthcare Stocks; PTC Therapeutics Rallies After Duchenne Muscular Dystrophy Dru

Small Advances for Healthcare Stocks; PTC Therapeutics Rallies After Duchenne Muscular Dystrophy Drug Approved

Sector Update: Healthcare

Benzinga's Volume Movers

See More PTCT News...